Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi

When it comes to courtroom brawls, petitioning the U.S. Supreme Court is typically a last-ditch effort. Now, after justices slapped down bids to rehear two separate cases, Novartis and Sanofi have reached the end of the line in their respective legal sagas.